Have questions for our experts or want more information?
Contact Us Today
Webinar Overview
Small molecule IND development attracts the largest share of investment and research yet a "one-size-fits-all" approach continues holding many programs back. In today’s competitive and rapidly evolving drug development landscape, understanding the nuances and nonclinical strategies that drive success is more critical than ever.
Discover how to adapt your approach to your program’s unique challenges to gain a competitive edge. By viewing this webinar, you will:
- Gain a fresh perspective on why tailored strategies are needed for different therapeutic goals
- Discover key nonclinical strategies that can set the foundation for successful clinical trial entry
- Learn how keeping the patient in mind positively influences your drug development strategy
Webinar Presenters
Manu Kohli, PhD
Principal Scientific Advisor
Charles River
Michael V. Templin, PhD, DABT
Director Senior Principal Scientific Advisor
Charles River